Dow Up 0.51% Nasdaq Up 0.24%

Stemline Therapeutics, Inc. (STML)

-NasdaqCM
14.00 Nov 21, 4:00PM EST
Prev Close:14.00
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:56.00
Beta:-4.709
Earnings Date:Feb 2 - Feb 6 (Est.)
Day's Range:N/A - N/A
52wk Range:10.50 - 31.48
Volume:0
Avg Vol (3m):156,202
Market Cap:181.43M
P/E (ttm):N/A
EPS (ttm):-2.30
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
STML 0.00%181.43M
OMED634.53M
VSTM231.23M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):636.90
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-2.31
Quarterly EPS Est (Dec-14) :-0.62
Mean Recommendation*:1.4
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Stemline Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, acquisition, development, and commercialization of proprietary therapeutics for cancer stem cells and bulk tumors in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback